Android app Apple app link

ACADIA Pharmaceuticals Inc. (ACAD) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$22.38

$0.1 (0.45%)
Last update: 02:41 PM EST
Day's range
$22.13
Day's range
$22.53

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
06/26/2025 Oppenheimer Matthew Hershenhorn $22.00 $22.55   -2.42%
05/20/2025 Morgan Stanley Sean Laaman $24.00 $21.69   10.65%
05/19/2025 Needham Ami Fadia $30.00 $21.98   36.52%
05/19/2025 H.C. Wainwright Andrew Fein $32.00 $21.98   45.62%
01/03/2025 Guggenheim Yatin Suneja $20.00 $18.49   8.17%
08/07/2024 Morgan Stanley Jeffrey Hung $20.00 $18.85   6.1%
06/26/2024 BMO Capital Keith Tapper $31.00 $15.50   100%
05/09/2024 H.C. Wainwright Andrew Fein $27.00 $17.13   57.62%
05/09/2024 Robert W. Baird Joel Beatty $28.00 $17.13   63.46%
05/09/2024 Mizuho Securities Uy Ear $21.00 $17.13   22.59%
04/30/2024 UBS Ashwani Verma $27.00 $17.10   57.89%
03/12/2024 UBS Ashwani Verma $33.00 $19.98   65.17%
03/12/2024 Oppenheimer Jay Olson $19.00 $19.98   -4.9%
03/12/2024 Needham Ami Fadia $32.00 $19.98   60.16%
03/12/2024 Canaccord Genuity Sumant Kulkami $33.00 $19.98   65.17%
03/11/2024 JMP Securities Jason Butler $39.00 $19.98   95.2%
01/24/2024 Needham Ami Fadia $37.00 $27.19   36.08%
02/28/2022 Stifel Nicolaus Paul Matteis $20.00 $25.07   -20.22%
02/28/2022 H.C. Wainwright Andrew Fein $36.00 $25.07   43.6%
02/28/2022 Bank of America Securities Tazeen Ahmad $31.00 $25.07   23.65%
02/28/2022 Citigroup Neena Bitritto-Garg $32.00 $25.07   27.64%
02/27/2022 Leerink Partners Marc Goodman $31.00 $25.41   22%
12/20/2021 Cowen & Co. Ritu Baral $32.00 $21.45   49.18%
12/20/2021 Guggenheim Yatin Suneja $28.00 $21.45   30.54%
12/06/2021 Oppenheimer Jay Olson $23.00 $21.32   7.88%
08/03/2021 J.P. Morgan Cory Kasimov $34.00 $21.05   61.52%
04/18/2021 Deutsche Bank Pito Chickering $62.00 $20.72   199.23%

ACADIA Pharmaceuticals Inc. FAQ's

ACADIA Pharmaceuticals Inc. has been rated by research analysts at Oppenheimer, Morgan Stanley, Needham, H.C. Wainwright, UBS, Guggenheim in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.